JNCCN 360 - Hepatobiliary

Hepatobiliary Cancer Coverage from Every Angle

ABOUT
SECTIONS
NCCN RESOURCES
360 HUB
JNCCN

Editor:

Al B. Benson III, MD, FACP, FASCO

Videos

Rachna T. Shroff, MD, on Using Gemcitabine, Cisplatin, and Nab-paclitaxel to Treat Biliary Tract Cancers

Richard S. Finn, MD, on Quality of Life With Tislelizumab Versus Sorafenib in HCC Treatment

Laura A. Dawson, MD, on Sorafenib vs Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma

James J. Harding, MD, on New Data on Neratinib for HER2-Positive Biliary Tract Cancer

Ghassan K. Abou-Alfa, MD, on Clinical Implications of Using Tremelimumab Plus Durvalumab for Unresectable Hepatocellular Carcinoma

Richard S. Finn, MD, on LEAP-002 Trial Findings on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma: Clinical Implications

JNCCN Spotlights ?

Tremelimumab Plus Durvalumab

Resources

For your Patients

Global Liver Institute

American Gastroenterlogical Association

American Liver Foundation

Cholangiocarcinoma Foundation

Sections

NCCN Resources

360 HUB
About
Contact
Disclaimer
Disclosures
Privacy Policy
Terms Of Use

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.

Bots not welcome here